Form 8-K - Current report:
SEC Accession No. 0001493152-22-004649
Filing Date
2022-02-15
Accepted
2022-02-15 11:07:23
Documents
17
Period of Report
2022-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50761
2 ex1-1.htm EX-1.1 386850
3 ex4-1.htm EX-4.1 124222
4 ex5-1.htm EX-5.1 15732
5 ex99-1.htm EX-99.1 9213
6 ex99-2.htm EX-99.2 10834
  Complete submission text file 0001493152-22-004649.txt   884040

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE envb-20220211.xsd EX-101.SCH 3030
8 XBRL LABEL FILE envb-20220211_lab.xml EX-101.LAB 34476
9 XBRL PRESENTATION FILE envb-20220211_pre.xml EX-101.PRE 22593
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3612
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 22637489
SIC: 2834 Pharmaceutical Preparations